MedPath

The effect of exercise on main iron regulator hormone in patients with Beta Thalassemia Intermedia

Not Applicable
Conditions
Beta Thalassemia Intermedia.
Beta thalassaemia
Registration Number
IRCT2015062516211N2
Lead Sponsor
Exercise Physiology Research Center,Baqiyatallah University of Medical Sciences Baqiyatallah
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1-Patients with Beta Thalassemia Intermedia.
2-Irregular blood transfusions or no blood transfusions.
3-Ejection Fraction more than 55%.
4-Pulmonary artery pressure or (PAP) less than of 30 mm Hg.
5-Lack of Hemochromatosis.
6-The absence of fractures in lower limbs.
7-Lack of diabetes.
Exclusion criteria:
1-Regular blood transfusions.
2-Iron overload in the heart.
3-Splenectomized patients.
4-Drugs such as Digoxin and other drugs associated with heart disease.
5-Personal desire, nausea, vomiting and headache during exercise.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Hepcidin. Timepoint: Before, immediately after and 3 hours after the intervention. Method of measurement: Blood sample and ELISA method.;Ferritin. Timepoint: Before, immediately after and 3 hours after the intervention. Method of measurement: Blood sample and Photometric method.
Secondary Outcome Measures
NameTimeMethod
24-hour dietary recall. Timepoint: 24 hour before primary blood sample. Method of measurement: By 24-hour dietary recall questionnaire.;Blood pressure. Timepoint: Before and after each period of practice. Method of measurement: By manual manometer and according to mm Hg.;RPE or Rate of Perception Effort. Timepoint: Before and after each period of practice. Method of measurement: 20-point Borg questionnaire.
© Copyright 2025. All Rights Reserved by MedPath